PD-1 expressed on tumor-infiltrating immune cells and PD-L1 expressed on antigen-presenting cells and tumor cells are interacting immune checkpoint proteins that negatively regulate anti-tumor adaptive immune responses14,15. This evidence concerns the gene CD274 and neoplasm.